These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 16521635
21. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. Voswinckel R, Enke B, Reichenberger F, Kohstall M, Kreckel A, Krick S, Gall H, Gessler T, Schmehl T, Ghofrani HA, Schermuly RT, Grimminger F, Rubin LJ, Seeger W, Olschewski H. J Am Coll Cardiol; 2006 Oct 17; 48(8):1672-81. PubMed ID: 17045906 [Abstract] [Full Text] [Related]
22. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases. Sablotzki A, Hentschel T, Hofmann S, Simm A, Mühling J, Czeslick E. J Clin Anesth; 2006 Mar 17; 18(2):108-13. PubMed ID: 16563327 [Abstract] [Full Text] [Related]
23. Oral tadalafil in pulmonary artery hypertension: a prospective study. Aggarwal P, Patial RK, Negi PC, Marwaha R. Indian Heart J; 2007 Mar 17; 59(4):329-35. PubMed ID: 19126938 [Abstract] [Full Text] [Related]
24. Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers. Zuo XR, Zhang R, Jiang X, Li XL, Zong F, Xie WP, Wang H, Jing ZC. Am J Cardiol; 2012 Jun 15; 109(12):1801-6. PubMed ID: 22459309 [Abstract] [Full Text] [Related]
25. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease? Madden BP, Sheth A, Wilde M, Ong YE. Vascul Pharmacol; 2007 Jun 15; 47(2-3):184-8. PubMed ID: 17627899 [Abstract] [Full Text] [Related]
26. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation. Mogollón Jiménez MV, Escoresca Ortega AM, Hinojosa Pérez R, Lage Gallé E, Herruzo Avilés A, Sobrino Márquez M, Frutos López M, Romero Rodríguez N, Pérez de la Yglesia R, Martínez Martínez A. Transplant Proc; 2008 Nov 15; 40(9):3009-11. PubMed ID: 19010174 [Abstract] [Full Text] [Related]
27. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Houde C, Bohn DJ, Freedom RM, Rabinovitch M. Br Heart J; 1993 Nov 15; 70(5):461-8. PubMed ID: 8260279 [Abstract] [Full Text] [Related]
28. [Therapy of primary pulmonary arterial hypertension: current status]. Solèr M. Schweiz Med Wochenschr; 1994 Oct 01; 124(39):1701-7. PubMed ID: 7939536 [Abstract] [Full Text] [Related]
30. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. Fattouch K, Sbraga F, Sampognaro R, Bianco G, Gucciardo M, Lavalle C, Vizza CD, Fedele F, Ruvolo G. J Cardiovasc Med (Hagerstown); 2006 Feb 01; 7(2):119-23. PubMed ID: 16645371 [Abstract] [Full Text] [Related]
31. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G. J Thorac Cardiovasc Surg; 2007 Mar 01; 133(3):689-95. PubMed ID: 17320566 [Abstract] [Full Text] [Related]
32. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group. J Heart Lung Transplant; 2006 Sep 01; 25(9):1070-6. PubMed ID: 16962468 [Abstract] [Full Text] [Related]
33. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Mukhopadhyay S, Sharma M, Ramakrishnan S, Yusuf J, Gupta MD, Bhamri N, Trehan V, Tyagi S. Circulation; 2006 Oct 24; 114(17):1807-10. PubMed ID: 17030688 [Abstract] [Full Text] [Related]
34. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Post MC, Janssens S, Van de Werf F, Budts W. Eur Heart J; 2004 Sep 24; 25(18):1651-6. PubMed ID: 15351165 [Abstract] [Full Text] [Related]
35. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Nagaya N, Uematsu M, Oya H, Sato N, Sakamaki F, Kyotani S, Ueno K, Nakanishi N, Yamagishi M, Miyatake K. Am J Respir Crit Care Med; 2001 Mar 24; 163(4):887-91. PubMed ID: 11282761 [Abstract] [Full Text] [Related]
36. The effect of treatment with eprosartan on pulse pressure: factors predicting response. de la Sierra A, Muñoz A, Arcos E, López JS, Relats J, ETAPA-2 study investigators. Can J Cardiol; 2004 Oct 24; 20 Suppl C():17C-22C. PubMed ID: 16807619 [Abstract] [Full Text] [Related]
37. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery. Shim JK, Choi YS, Oh YJ, Kim DH, Hong YW, Kwak YL. J Thorac Cardiovasc Surg; 2006 Dec 24; 132(6):1420-5. PubMed ID: 17140970 [Abstract] [Full Text] [Related]
38. Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study. Skoro-Sajer N, Hack N, Sadushi-Koliçi R, Bonderman D, Jakowitsch J, Klepetko W, Hoda MA, Kneussl MP, Fedullo P, Lang IM. Circulation; 2009 Jan 20; 119(2):298-305. PubMed ID: 19118254 [Abstract] [Full Text] [Related]
39. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R. Vascul Pharmacol; 2005 Sep 20; 43(3):143-7. PubMed ID: 16061423 [Abstract] [Full Text] [Related]